Spyre Announces SPY003 Induction Results Showing Best-in-Class Potential
Spyre reported positive Phase 2 SKYLINE data for SPY003, a potential best-in-class anti-IL-23. The results met its endpoints with clinically meaningful improvements and a well-tolerated safety profile.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day